Skip to content

CDR

Canadian food/drug retail market in state of flux

The prelude to Loblaw Cos.’ blockbuster deal to buy Shoppers Drug Mart Corp. reflects pressures that are shaking up the playing field in Canada’s food and drug retail market. Loblaw’s proposal to buy Shoppers Drug Mart would merge Canada’s largest grocery and pharmacy retailers. Expansion by huge U.

MinuteClinic adds locations in Virginia

MinuteClinic has opened its first location in southwestern Virginia and soon plans more clinics in the area. The CVS Caremark retail health clinic subsidiary said Thursday that the new MinuteClinic inside its CVS/pharmacy store in Christiansburg, Va.

Catalina Health acquired by inVentiv Health

Digital media company Catalina has sold its Catalina Health division to inVentiv Health, a global provider of clinical, commercial and consulting services to the life sciences industry. Catalina said late Wednesday that it closed the deal Oct.

No7 introduces Lift & Luminate Day & Night Serum

Next month, Boots plans to extend its No7 skin care line in the United States with Lift & Luminate Day & Night Serum. The company said Wednesday that the two-step system targets the three main signs of aging — uneven skin tone, the appearance of lines and wrinkles, and the loss of

iMedicare grows pharmacy base for Medicare Part D tool

iMedicare, a comparison platform for Medicare prescription drug plans, is now available in 500 pharmacies nationwide. The company said Wednesday that its Medicare decision-making technology helps thousands of seniors enroll in affordable drug benefit plans and health insurance coverage.

Shoppers Drug Mart unveils new beautyBOUTIQUE

Shoppers Drug Mart Corp. has opened the latest iteration of its beautyBOUTIQUE store-within-store concept in Toronto. CEO Domenic Pilla introduces the new beautyBOUTIQUE iat the chain’s Toronto Eaton Centre store.

Endo to purchase Boca Pharmacal

In another example of pharmaceutical industry consolidation, Endo Health Solutions — through its Qualitest subsidiary — is acquiring privately held Boca Pharmacal, a specialty generic drug firm, for $225 million in cash.